Back to results

$35M QVAR Inhaler Settlement Resolves Teva Pharmaceuticals Antitrust Lawsuit

via ClassAction.org Published: May 06, 2026

Summary

A $35M QVAR settlement ends a class action lawsuit that alleges Teva illegally sought to block competition for its inhaler products.

Read full article →